Thymosin alpha-1 has been studied as an immune adjunct in hepatitis, sepsis and oncology, with mixed results. These trials do not establish benefits for training recovery or general immunity in healthy people.
Key points
- Clinical trials target specific diseases.
- A large sepsis trial did not show a mortality benefit.
- Not distinct from TB-500, despite frequent confusion.
- Products sold online under this name have not been independently verified; label identity and concentration cannot be assumed.
What the literature shows
Wu and colleagues ran a multicentre randomised trial of thymosin alpha-1 in sepsis and found no significant reduction in 28-day mortality.
Reviews summarise hepatitis and oncology adjunct studies with heterogeneous quality.
What remains unknown
- Effects in healthy, immunocompetent adults.
- Long-term immune modulation consequences.
Safety and monitoring implications
- Immune-modulating claims should not replace vaccination or medical care.
- Injection sterility remains a key risk.
Cited literature
- 1.Wu J, Pei F, Zhou L, et al. (2025). The efficacy and safety of thymosin α1 for sepsis (TESTS): multicentre, double blinded, randomised, placebo controlled, phase 3 trial. BMJ. Find on PubMed
- 2.King R, Tuthill C. (2016). Immune modulation with thymosin alpha 1 treatment. Vitamins and Hormones. Find on PubMed
Community reports
Anecdotal — not scientific evidence
Lived experience is valuable context and often surfaces problems before the literature does. It is also uncontrolled, unverified and subject to bias, so it never overrides published findings here.
Editorial evidence status
MixedCommunity discussion of this compound is widespread, but no independently verified reports were available for this analysis. Anecdotes have not been invented or treated as clinical evidence.
Buying Thymosin alpha-1 / thymalfasin in Australia: what to check first
APEDRA does not sell Thymosin alpha-1 / thymalfasin or any other product, and takes no commission from suppliers. If you are researching where to buy it, the biggest practical risk is not the compound itself but what is actually in the bottle: under-dosing, substitution with a different compound, and contamination are all documented in independent testing of online research chemicals.
- Ask for a batch-specific third-party lab report (HPLC/mass spectrometry), not a generic certificate.
- Check independent review platforms, not only reviews hosted on the seller's own site.
- Read the shipping, returns and refund policies before ordering.
- Be wary of prices far below the market or exaggerated results claims.
Compare Australian vendors independently · how we assess suppliers
Terms used here are defined in our glossary, and the evidence-grading scale explains what this analysis's grade means. If you believe something here is wrong, tell us.
This analysis is educational. It is not medical advice, a dosing recommendation, or an endorsement of use. Speak with a qualified medical practitioner about your circumstances.